| Gene symbol | DKK3 | Synonyms | CRRL, REIC, RIG | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11p15.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | dickkopf WNT signaling pathway inhibitor 3 | ||||
| GTO ID | GTC1122 |
| Trial ID | JPRN-UMIN000004929 |
| Disease | Prostate Cancer |
| Altered gene | DKK3 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV-DKK3 |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | A clinical study of adenovirus mediated Reduced Expression in Immortalized Cells/Dickkopf-3(REIC/Dkk-3)gene therapy for prostate cancer |
| Year | 2011 |
| Country | Japan|North America |
| Company sponsor | National Cancer Institute (NCI) |
| Vector information | |||||||||
|
|||||||||
| Cohort1: dose level 1 | |||||||||
|
|||||||||
| Cohort2: dose level 2 | |||||||||
|
|||||||||
| Cohort3: dose level 3 | |||||||||
|
|||||||||